Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia

dc.authorid0000-0002-3650-7087
dc.authorid0000-0001-5319-0547
dc.authorid0000-0001-7287-1276
dc.authorid0000-0003-1588-8519
dc.authorid0000-0002-8648-213X
dc.authorid0000-0001-6969-6649
dc.authorid0000-0002-3370-8545
dc.contributor.authorNg, O. H.
dc.contributor.authorErbilgin, Y.
dc.contributor.authorFirtina, S.
dc.contributor.authorCelkan, T.
dc.contributor.authorKarakas, Z.
dc.contributor.authorAydogan, G.
dc.contributor.authorTurkkan, E.
dc.date.accessioned2025-05-10T19:44:11Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractWNT signaling has been implicated in the regulation of hematopoietic stem cells and plays an important role during T-cell development in thymus. Here we investigated WNT pathway activation in childhood T-cell acute lymphoblastic leukemia (T-ALL) patients. To evaluate the potential role of WNT signaling in T-cell leukomogenesis, we performed expression analysis of key components of WNT pathway. More than 85% of the childhood T-ALL patients showed upregulated beta-catenin expression at the protein level compared with normal human thymocytes. The impact of this upregulation was reflected in high expression of known target genes (AXIN2, c-MYC, TCF1 and LEF). Especially AXIN2, the universal target gene of WNT pathway, was upregulated at both mRNA and protein levels in similar to 40% of the patients. When beta-CATENIN gene was silenced by small interfering RNA, the cancer cells showed higher rates of apoptosis. These results demonstrate that abnormal WNT signaling activation occurs in a significant fraction of human T-ALL cases independent of known T-ALL risk factors. We conclude that deregulated WNT signaling is a novel oncogenic event in childhood T-ALL.
dc.description.sponsorshipResearch Fund of the Istanbul University [355/03062005, 5785, 11021]; Turkish Society of Hematology, Scientific and Technical Research Council of Turkey-TUBITAK [106S112, 109S395]; Turkish Republic Prime Ministry State Planning Organization-DPT [2005K120430]; EMBO short-term fellowship program [326-2008]; Erasmus MC-Querido Chair Exchange Scholarship; AICR [07-0049]; Kika [09-36]
dc.description.sponsorshipThis work is supported by the Research Fund of the Istanbul University (Project no. 355/03062005, 5785 and 11021), Turkish Society of Hematology, Scientific and Technical Research Council of Turkey-TUBITAK (Project no: 106S112 and 109S395), Turkish Republic Prime Ministry State Planning Organization-DPT (Project no: 2005K120430). O. Hatirnaz Ng was partially supported by EMBO short-term fellowship program (ASTF no: 326-2008) and Erasmus MC-Querido Chair Exchange Scholarship. FJT Staal is supported in part by the AICR (07-0049) and Kika (09-36).
dc.identifier.doi10.1038/bcj.2014.12
dc.identifier.issn2044-5385
dc.identifier.pmid24632884
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1038/bcj.2014.12
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10862
dc.identifier.volume4
dc.identifier.wosWOS:000334494800004
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.ispartofBlood Cancer Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectBeta-Catenin Mutation
dc.subjectTranscription Factor
dc.subjectExpression
dc.subjectGene
dc.subjectActivation
dc.subjectTransformation
dc.subjectThymocytes
dc.subjectCarcinoma
dc.subjectPathways
dc.titleDeregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10861.pdf
Boyut:
1.49 MB
Biçim:
Adobe Portable Document Format